Masimo Corporation
MASI
Rangering i aksjer
#2170
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Aksjekurs
$179.95
Sist synkronisert: 2026-06-12
Markedsverdi
$9.42B
Endring (1 dag)
0.00%
Endring (1 år)
22.41%
Land
US
Handel Masimo Corporation (MASI)
Kategori
Healthcare
P/S-forhold for Masimo Corporation (MASI)
P/S-forhold per October 2026 TTM: 6.05
Ifølge Masimo Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 6.05. Ved slutten av 2023 hadde selskapet et P/S-forhold på 3.02.
P/S-historikk for Masimo Corporation fra 2002 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 6.05 | 39.00% |
| 2024 | 4.35 | 43.99% |
| 2023 | 3.02 | -22.43% |
| 2022 | 3.90 | -69.65% |
| 2021 | 12.84 | 41.25% |
| 2019 | 9.09 | 31.85% |
| 2018 | 6.89 | 24.68% |
| 2017 | 5.53 | 18.05% |
| 2016 | 4.68 | 94.02% |
| 2015 | 2.41 | -19.27% |
| 2013 | 2.99 | 24.73% |
| 2012 | 2.40 | -5.61% |
| 2011 | 2.54 | -49.41% |
| 2010 | 5.02 | -7.86% |
| 2009 | 5.45 | -36.94% |
| 2007 | 8.64 | 468.76% |
| 2006 | 1.52 | -77.03% |
| 2005 | 6.61 | -35.71% |
| 2004 | 10.29 | -32.62% |
| 2003 | 15.27 | -16.91% |
| 2002 | 18.37 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 3.82 | -36.75% |
US
|
|
| 2.78 | -53.94% |
IE
|
|
| 4.18 | -30.89% |
US
|
|
| 2.97 | -50.88% |
US
|
|
| - | - |
DE
|
